PDF file - 121K, Distribution and Reproducibility of Scores from SMARTpool Interactions with MLN4924 in A375 Melanoma Cell Line
PDF file - 355K, Effect of Gene Knock-down on Cell Cycle Distribution of A375 Melanoma Cells in Combination with Vehicle
Supplementary Fig. S1 from Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib
Supplementary Data, Figure Legends 1-3 from Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Supplementary Figures 5-7 from Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib
PDF file - 339KB, Comparison of Isobolograms Calculated for Drug Response Surface Plots for 10 Different Agents.
Supplementary Figure 1 from Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Supplementary Figure 3 from Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Supplementary Figures 1-4 from Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib
Supplementary Figure 2 from Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
PDF file - 145KB, Comparison of the Degree of Interaction between MLN4924 and 14 Different Agents as Measured by Nonlinear Blending Values.
PDF file - 402KB, The Combination of MLN4924 and Mitomycin C Leads to Increased DNA Strand Breaks.
Supplementary Fig. S2 from Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib
PDF file - 162K, Genes Selected Based upon Extreme BI Scores are More Likely to Have Extreme Deconvoluted Oligo Scores than Those Selected Based upon Biology or Randomly
Supplementary Figure 8 from Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib
Khristofer Garcia合作论文数38Lightcap Eric S合作论文数Departments of Discovery, Clinical Biostatistics, and Information Technology, Takeda Pharmaceuticals International Co.28Xiaozhen Liu合作论文数22David C. Bouck合作论文数Department of Biology;University of North Carolina at Chapel Hill;Department of Biology, University of North Carolina at Chapel Hill20Greg Hather合作论文数17Liu Ray合作论文数17Darshan S. Sappal合作论文数17Paul Hales合作论文数16Cosmopoulos Katherine合作论文数15Michael D. Pickard合作论文数15Christopher Tsu合作论文数15Jane Liu合作论文数14Fleming Paul R合作论文数13R. A. John Challiss合作论文数12Peter Smith合作论文数11Mike Kuranda合作论文数10Yu Jie合作论文数10Hugues Bernard合作论文数10Yueying Cao合作论文数10
Mark Rolfe合作论文数10Allison J. Berger合作论文数10Michael P. Thomas合作论文数10Frank Bruzzese合作论文数8Syamala Bandi合作论文数8Lawrence R Dick合作论文数Millennium Pharmaceut Inc, Cambridge, MA 02139 USA8
John H. Exton合作论文数Vanderbilt University8Mark Manfredi合作论文数8Larry Dick合作论文数7Bret Bannerman合作论文数7Erik Kupperman合作论文数7Olga Tayber合作论文数7Michael Fitzgerald合作论文数7Frank J. Bruzzese合作论文数7Usha Narayanan合作论文数6Milhollen Michael A合作论文数6Karl Deacon合作论文数Respiratory Biomedical research Unit;City Hospital6James J. Spelman合作论文数5John Ringeling合作论文数5Anne L. Burkhardt合作论文数5Jay P. Morgenstern合作论文数5Jesse Gray合作论文数5Trupti Lingaraj合作论文数5Denise L. Driscoll合作论文数5David M. Rappoli合作论文数5Theodore Peters合作论文数5Joe Bolen合作论文数5Saurabh Menon合作论文数5Patrick Leroy合作论文数5Siquan Chen合作论文数5
